Skip to main content

Advertisement

Table 5 Summary oxygen consumption (VO2, L/min) measures resulting from five upper body power tests

From: Influence of an alkalizing supplement on markers of endurance performance using a double-blind placebo-controlled design

Group Test Period Constant Power Test UBP10 Test Trial #1 UBP10 Test Trial #2 UBP10 Test Trial #3 UBP60 Test
Placebo (n = 12) Pre-Test 2.68 ± 0.28 2.29 ± 0.22 2.55 ± 0.20 2.63 ± 0.19 3.14 ± 0.24
  Post-Test 2.72 ± 0.30 2.47 ± 0.23 2.88 ± 0.23 2.74 ± 0.21 ‡3.38 ± 0.26
Treatment (n = 12) Pre-Test 2.84 ± 0.29 2.34 ± 0.18 2.61 ± 0.17 2.65 ± 0.19 3.43 ± 0.25
  Post-Test †2.77 ± 0.28 2.33 ± 0.21 2.67 ± 0.23 2.68 ± 0.20 ‡3.26 ± 0.26
  1. NOTE: All values expressed as Mean ± SE; UBP10 = 10-sec upper body power test; UBP60 = 60-sec upper body power test
  2. †Post-test measure of VO2 for Constant -Power test was nearly significantly lower than pre-test measure within the treatment group (P < 0.10)
  3. ‡Post-test measure of VO2 for UBP60 test were significantly different than pre-test measure within the corresponding test group (P < 0.05)